Browse by category

German Real-World Registry shows meaningful and sustained weight loss for at least one year after a single Revita endoscopic procedure

Fractyl Health has announced new weight maintenance and blood sugar clinical results from the Company’s German Real-World Registry for...

FDA grants Breakthrough Device Designation for Fractyl’s Revita in weight maintenance for people with obesity who discontinue GLP-1s

The FDA has granted Breakthrough Device Designation (BDD) for Fractyl Health’s Revita System for use in the maintenance of weight loss...

Revita results in weight loss and sustained weight maintenance without weight regain at one year

The latest weight maintenance data from a pooled analysis of patients enrolled in Revita (Fractyl Health) clinical studies across the EU...

Rejuva GLP-1-based pancreatic gene therapy candidate results in greater weight loss vs. semaglutide

Fractyl Health has revealed preclinical findings from its Rejuva gene therapy platform at the European Association for the Study of...

GLP-1 RAs found to shrink heart muscle in mice and human cells

23 hours ago

Ingestible capsule pumps drugs directly into the walls of the GI tract

23 hours ago

Tracking leptin pulse patterns offers a potential clue to understanding obesity

23 hours ago

Weekly Digest